Showing 1151-1160 of 18586 results for "".
Impacts on Access to Eye Care: Key Socioeconomic Factors
https://reachmd.com/programs/clinicians-roundtable/impacts-on-access-to-eye-care-key-socioeconomic-factors/14631/Have recent findings helped clinicians better identify socioeconomic factors among patients with glaucoma? Find out.Navigating Diagnostic Challenges in Food Protein-Induced Enterocolitis Syndrome
https://reachmd.com/programs/frontlines-food-allergies/navigating-diagnostic-challenges-in-food-protein-induced-enterocolitis-syndrome/30041/Food protein-induced enterocolitis syndrome (FPIES) is a rare, non-IgE-mediated food allergy in infants and young children that causes delayed, severe gastrointestinal symptoms without typical allergic signs. Learn about the challenges associated with diagnosing FPIES with Dr. Anna Nowak-Wegryzn, PrLong-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
https://reachmd.com/programs/project-oncology/long-term-survival-data-in-high-risk-nsclc-insights-from-real-world-practice/35995/While clinical trials have demonstrated the value of immunotherapy in advanced non-small cell lung cancer (NSCLC), real-world outcomes often reflect a more complex picture. That’s why a retrospective analysis of more than 17,000 patients examined 5-year survival and progression-free survival in patiImproving Cardiovascular Care with Timely Chronic Kidney Disease Diagnosis
https://reachmd.com/programs/conversations-in-cv-risk-assessment/improving-cv-care-ckd-diagnosis/36251/Delayed diagnosis of chronic kidney disease (CKD) may prevent timely identification and treatment of cardiovascular risk. However, by measuring albuminuria and identifying individuals with CKD early, clinicians can start patients on disease-modifying therapies, reducing cardiovascular complicationsUnmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
https://reachmd.com/programs/living-rheum/unmasking-igg4-related-disease-best-practices-for-accurate-diagnosis-and-optimal-care/32788/IgG4-related disease presents significant diagnostic challenges with diverse symptoms across organ systems. Dr. Matthew Baker, Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Founder and Co-Director of the Stanford Multidisciplinary SarcoidosChallenges of Implementing Evidence-Based Guidance for IgA Nephropathy
https://reachmd.com/programs/kdigo-conversations-nephrology/challenges-of-implementing-evidence-based-guidance-for-iga-nephropathy/37118/In this episode of KDIGO Conversations in Nephrology, host Dr. Dana Rizk welcomes Dr. Suneel Udani to discuss the challenges and opportunities of adopting the updated KDIGO guidelines for IgA nephropathy (IgAN). Their conversation highlights a shift in therapeutic goals and a new paradigm of simultaUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
https://reachmd.com/programs/neurofrontiers/fmri-early-alzheimers-subgroups/40003/Preclinical Alzheimer’s disease presents a unique challenge due to its silent progression and biological complexity. However, emerging data highlights the role of brain connectivity in distinguishing patient subtypes before clinical symptoms arise. Join Dr. Hamid Abuwarda as he discusses how functioIdentifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak
https://reachmd.com/programs/clinicians-roundtable/identifying-mpox-hospitalization-risks-in-patients-with-hiv-during-the-2022-outbreak/32853/During the 2022 mpox outbreak, New York City emerged as the epicenter, with disproportionate impacts on gay and bisexual men. A new study presented at IDWeek 2025 examines how HIV-related factors, such as CD4 count, ART status, and syphilis co-infection, shaped mpox severity and hospitalization riskPrevention on the Horizon: Early Intervention and Risk Reduction in MS Care
https://reachmd.com/programs/frontlines-multiple-sclerosis/prevention-on-the-horizon-early-intervention-and-risk-reduction-in-ms-care/36389/Understanding and identifying early risk factors for multiple sclerosis (MS) is critical to shifting care toward prevention and minimizing long-term disease burden. Ashley Baker sits down with Dr. Vikram Bhise to discuss how emerging biomarkers and updated diagnostic criteria could enable earlier inAdvancing Myopia Detection and Treatment: A Look at Novel Innovations
https://reachmd.com/programs/eye-on-ocular-health/advancing-myopia-detection-and-treatment-a-look-at-novel-innovations/36444/With global myopia rates on the rise, clinicians face increasing pressure to detect and manage the condition earlier and more effectively. Fortunately, advancements such as novel lens technologies, low-dose atropine therapy, and AI-driven predictive tools have the potential to reshape the future of